REQUEST A DEMO
Total
USD $0.00
Search more companies

Optus Pharmaceutical Co., Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Optus Pharmaceutical Co., Ltd. Profile Updated: July 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

DHP Korea Co.,Ltd. is engaged in developing, manufacturing and distribution of ETC and OTC medicines. The company offers ophthalmology products including eye drops, healthcare products and cosmetics. DHP Korea Co.,Ltd. is based in Seoul with a manufacturing facility in Cheongju, South Korea. The company was established in 2005.

Headquarters
25-5 Yoido-Dong, Yeongdeungpo-Gu
Seoul; Seoul; Postal Code: 150-010

Contact Details: Purchase the Optus Pharmaceutical Co., Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Optus Pharmaceutical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Optus Pharmaceutical Co., Ltd. report to view the information.
Registered Capital:
Purchase the Optus Pharmaceutical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Optus Pharmaceutical Co., Ltd. report to view the information.
Incorporation Date:
July 27, 2010
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
4.14%
Purchase this report to view the information.
0.38%
Purchase this report to view the information.
0.13%
Subsidiaries
(주)디에이치피코리아
Company Performance
Financial values in the chart are available after Optus Pharmaceutical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
5.5%
Total operating revenue
7.78%
Operating profit (EBIT)
-45.33%
EBITDA
-34.97%
Net Profit (Loss) for the Period
-33.52%
Total assets
16.81%
Total equity
13.38%
Operating Profit Margin (ROS)
-13.21%
Net Profit Margin
-8.48%
Return on Equity (ROE)
-4.09%
Quick Ratio
-6.88%
Cash Ratio
-4.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?